Preface
Cancer immunotherapy—the end of the beginning
Chinese Clinical Oncology
2018;
7
(2)
:12
.
(29 April 2018)
Review Article
What is the role of immunotherapy in breast cancer
Chinese Clinical Oncology
2018;
7
(2)
:13
.
(29 April 2018)
Emerging role of immunotherapy for childhood cancers
Chinese Clinical Oncology
2018;
7
(2)
:14
.
(29 April 2018)
Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma
Chinese Clinical Oncology
2018;
7
(2)
:15
.
(29 April 2018)
The emerging role of oncolytic virus therapy against cancer
Chinese Clinical Oncology
2018;
7
(2)
:16
.
(29 April 2018)
The evolving role of immune oncology in colorectal cancer
Chinese Clinical Oncology
2018;
7
(2)
:17
.
(29 April 2018)
Editorial
Onward and upward for immuno-oncology
Chinese Clinical Oncology
2018;
7
(2)
:18
.
(29 April 2018)
Perspective
Immunoregulatory antigens—novel targets for cancer immunotherapy
Chinese Clinical Oncology
2018;
7
(2)
:19
.
(29 April 2018)
Developing academic cancer immunotherapy in Asia—lessons, challenges, and a vision for Thailand
Chinese Clinical Oncology
2018;
7
(2)
:20
.
(29 April 2018)
Chimeric antigen receptor T cells, a savior with a high price
Chinese Clinical Oncology
2018;
7
(2)
:21
.
(29 April 2018)
Disclosure:
The focused issue “Cancer Immunotherapy” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Han Chong Toh served as the unpaid Guest Editor for the focused issue.
